(Q43894830)

27 November 2017

A chloroplast-derived C4V3 polypeptide from the human immunodeficiency virus (HIV) is orally immunogenic in mice (English)

1 reference

27 November 2017

Néstor Rubio-Infante

1

1 reference

27 November 2017

Dania O Govea-Alonso

2

1 reference

27 November 2017

Ángel G Alpuche-Solís

3

1 reference

27 November 2017

Ana Lilia García-Hernández

4

1 reference

27 November 2017

Ruth E Soria-Guerra

5

1 reference

27 November 2017

L M Teresita Paz-Maldonado

6

1 reference

27 November 2017

Damaris Ilhuicatzi-Alvarado

7

1 reference

27 November 2017

Javier T Varona-Santos

8

1 reference

27 November 2017

Leticia Verdín-Terán

9

1 reference

27 November 2017

Schuyler S Korban

10

1 reference

27 November 2017

Leticia Moreno-Fierros

11

1 reference

27 November 2017

Sergio Rosales-Mendoza

12

1 reference

27 November 2017

7 January 2012

1 reference

27 November 2017

Plant Molecular Biology

1 reference

27 November 2017

78

1 reference

27 November 2017

4-5

1 reference

27 November 2017

337-349

1 reference

https://scigraph.springernature.com/pub.10.1007/s11103-011-9870-1

27 November 2017

0 references

cites work

HIV-1 vaccine development after STEP.

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

Impaired plant growth and development caused by human immunodeficiency virus type 1 Tat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

Mucosal and systemic adjuvant effects of cholera toxin and Cry1Ac protoxin on the specific antibody response to HIV-1 C4/V3 peptides are different and depend on the antigen co-administered

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

Potent cross-group neutralization of primary human immunodeficiency virus isolates with monoclonal antibodies--implications for acquired immunodeficiency syndrome vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

Immunogenicity of chloroplast-derived HIV-1 p24 and a p24-Nef fusion protein following subcutaneous and oral administration in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

An HIV vaccine--challenges and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

HIV-1 gp120 V3 cholera toxin B subunit fusion gene expression in transgenic potato

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

Production of the 42-kDa fragment of Plasmodium falciparum merozoite surface protein 1, a leading malaria vaccine antigen, in Arabidopsis thaliana seeds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

Chloroplast-derived vaccines against human diseases: achievements, challenges and scopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

Expression of HIV-1 antigens in plants as potential subunit vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

GP120: target for neutralizing HIV-1 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

Plant-made immunogens and effective delivery strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

Expression of an Escherichia coli antigenic fusion protein comprising the heat labile toxin B subunit and the heat stable toxin, and its assembly as a functional oligomer in transplastomic tobacco plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

High-level expression of the HIV-1 Pr55gag polyprotein in transgenic tobacco chloroplasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

Plant-based anti-HIV-1 strategies: vaccine molecules and antiviral approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

Two decades of plant-based candidate vaccines: a review of the chimeric protein approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

Production of a short recombinant C4V3 HIV-1 immunogen that induces strong anti-HIV responses by systemic and mucosal routes without the need of adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

Is there a role for plant-made vaccines in the prevention of HIV/AIDS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

Selective modification of variable loops alters tropism and enhances immunogenicity of human immunodeficiency virus type 1 envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

High-level expression of human immunodeficiency virus antigens from the tobacco and tomato plastid genomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11103-011-9870-1

Mycobacterial di-O-acyl-trehalose inhibits mitogen- and antigen-induced proliferation of murine T cells in vitro

21 January 2018

1 reference

12 December 2020

Chloroplast genetic engineering to improve agronomic traits.

1 reference

12 December 2020

Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A)

1 reference

12 December 2020

Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies

1 reference

12 December 2020

Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys

1 reference

12 December 2020

10.1007/S11103-011-9870-1

Identifiers

DOI

1 reference

Dimensions Publication ID

27 November 2017

0 references

1 reference